PTX3 and bronchopulmonary dysplasia: Furthermore, the therapeutic effect and mechanism involving PTX3 were tested in an animal model of bronchopulmonary dysplasia, a representative inflammatory disease, and evidence for determining the minimum standards for PTX3 was acquired.